In:
PLOS ONE, Public Library of Science (PLoS), Vol. 16, No. 6 ( 2021-6-16), p. e0253170-
Abstract:
Clofarabine, an FDA approved purine analog, is used in the treatment of relapsed or refractory acute lymphoblastic leukemia. Clofarabine acts by inhibiting DNA synthesis. We demonstrated that clofarabine may have a novel function though inhibiting CD99, a transmembrane protein highly expressed on Ewing Sarcoma (ES) cells. CD99 is a validated target in ES whose inhibition may lead to a high therapeutic index for patients. Here we present additional data to support the hypothesis that clofarabine acts on CD99 and regulates key signaling pathways in ES. Cellular thermal shift assay indicated a direct interaction between clofarabine and CD99 in ES cell lysates. Clofarabine induced ES cell death does not require clofarabine’s conversion to its active form by deoxycytidine kinase. A phosphokinase array screen with clofarabine and a CD99 blocking antibody identified alterations in signaling pathways. CD99 inhibition with clofarabine in ES cells caused rapid and sustained phosphorylation of ERK, MSK, and CREB. However, activation of this pathway did not correlate with clofarabine induced ES cell death. In summary, we demonstrated that clofarabine may activate ERK, MSK, and CREB phosphorylation through CD99 within minutes, however this paradoxical activation and subsequent ES cell death requires additional investigation.
Type of Medium:
Online Resource
ISSN:
1932-6203
DOI:
10.1371/journal.pone.0253170
DOI:
10.1371/journal.pone.0253170.g001
DOI:
10.1371/journal.pone.0253170.g002
DOI:
10.1371/journal.pone.0253170.g003
DOI:
10.1371/journal.pone.0253170.g004
DOI:
10.1371/journal.pone.0253170.g005
DOI:
10.1371/journal.pone.0253170.s001
DOI:
10.1371/journal.pone.0253170.s002
DOI:
10.1371/journal.pone.0253170.s003
DOI:
10.1371/journal.pone.0253170.s004
DOI:
10.1371/journal.pone.0253170.s005
DOI:
10.1371/journal.pone.0253170.s006
DOI:
10.1371/journal.pone.0253170.s007
Language:
English
Publisher:
Public Library of Science (PLoS)
Publication Date:
2021
detail.hit.zdb_id:
2267670-3
Bookmarklink